CraniUS Therapeutics is a privately held neurotechnology company developing a fully implantable, skull-embedded platform (NeuroPASS™) to bypass the blood-brain barrier for targeted drug delivery and monitoring in the brain. The company focuses on transforming cranial implants into active therapeutic interfaces to support long-term outpatient care for neurological diseases and brain cancer.
Leadership & Board
Current Number of Employees20
Current LinkedIn Followers2,124
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$20M
Total Amount Raised$20M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$20M
Latest Funding Amount$20M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
CraniUS Therapeutics had 20 employees as of September 28, 2026. The number of employees increased by 0 (0.00%) week-over-week.
20Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
CraniUS Therapeutics had 2,124 followers as of September 28, 2026. The number of followers increased by 10 (0.47%) week-over-week.
2,124Latest Followers Count
10(0.47%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.